Ország: Ausztrália
Nyelv: angol
Forrás: Department of Health (Therapeutic Goods Administration)
hydralazine hydrochloride, Quantity: 20 mg
Amdipharm Mercury Australia Pty Ltd
Injection, powder for
Excipient Ingredients:
Intravenous
5 X 20mg ampoules
(S4) Prescription Only Medicine
Hypertensive crises, especially during late pregnancy (pre-eclampsia and eclampsia).
Visual Identification: White to yellowish lyophilisation residue (cake).; Container Type: Ampoule; Container Life Time: 5 Years; Container Temperature: Store below 25 degrees Celsius
Registered
1993-02-15
APRESOLINE ® _hydralazine hydrochloride_ CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS CMI This CMI answers some common questions about Apresoline. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of giving you Apresoline against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS INFORMATION. You may need to read it again. WHAT APRESOLINE IS USED FOR Apresoline is an injection that is used when your blood pressure is very high and needs to be brought down quickly. Apresoline is used to reduce very high blood pressure especially during late pregnancy. Apresoline belongs to a group of medicines called vasodilators. It acts by relaxing and widening (dilating) the walls of blood vessels. This action helps to reduce blood pressure and increase blood and oxygen supply to the heart, brain, spleen and kidneys. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another purpose. Apresoline is only available with a doctor's prescription. It is not addictive. BEFORE YOU ARE GIVEN APRESOLINE _WHEN YOU MUST NOT HAVE IT_ YOU MUST NOT BE GIVEN APRESOLINE IF YOU HAVE EVER HAD AN ALLERGIC REACTION TO: • hydralazine, the active ingredient in Apresoline • dihydralazine • any of the ingredients listed at the end of this leaflet. Some of the symptoms of an allergic reaction may include: • shortness of breath • wheezing or difficulty breathing • swelling of the face, lips, tongue or other parts of the body • rash, itching or hives on the skin. YOU MUST NOT HAVE APRESOLINE IF YOU HAVE ANY OF THESE MEDICAL CONDITIONS: • Systemic lupus erythematosus (SLE) or a related disease • recent heart attack or other severe heart problems, e.g. due to inflammation around the heart, narrowing of blood vessels o Olvassa el a teljes dokumentumot
APRESOLINE ® 1 AUSTRALIAN PRODUCT INFORMATION APRESOLINE ® HYDRALAZINE HYDROCHLORIDE POWDER FOR INJECTION 1 NAME OF THE MEDICINE Hydralazine hydrochloride 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ampoule contains 20 mg hydralazine hydrochloride. 3 PHARMACEUTICAL FORM Hydralazine hydrochloride is a white to yellowish odourless crystalline powder. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Hypertensive crises, especially during late pregnancy (pre-eclampsia and eclampsia). 4.2 DOSE AND METHOD OF ADMINISTRATION Treatment with Apresoline for injection should always be carried out with caution and under strict medical surveillance (if possible in hospital). ADULT DOSAGE The initial dose is 5 to 10 mg, administered by slow intravenous injection in order to avoid precipitous decreases in mean arterial pressure with a critical reduction in cerebral or utero- placental perfusion. If it is necessary to repeat the injection, this should be done after an interval of 20 to 30 minutes, throughout which the blood pressure and heart rate should be monitored. A satisfactory response can be defined as a decrease in diastolic blood pressure to 90 to 100 mm Hg. Apresoline may also be given by continuous intravenous infusion, beginning with a flow rate of 200 to 300 micograms/min. Maintenance flow rates must be determined individually and are usually within the range of 50 to 150 micrograms/min. APRESOLINE ® 2 INSTRUCTIONS FOR USE Prior to each injection, the contents of the ampoule should be completely dissolved in 1 mL water for injections. The freshly prepared solution should be used immediately. For the preparation of infusion solutions, this fresh solution should be diluted with sodium chloride intravenous infusion 9 mg/mL. Glucose infusion solutions are not compatible because contact between hydralazine and glucose causes the active substance to be rapidly broken down. The product contains no antimicrobial preservative. Infusion of the reconstituted injection and of admixtures of the injection should be commen Olvassa el a teljes dokumentumot